Anabolic steroids for the treatment of weight loss in HIV-infected individuals: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anabolic Steroids for the Treatment of Weight Loss in HIV-infected Individuals: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435912/2/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome:_Cochrane_systematic_review. Accessed 17 April 2024.
Anabolic steroids for the treatment of weight loss in HIV-infected individuals: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435912/2/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome:_Cochrane_systematic_review. Accessed April 17, 2024.
Anabolic steroids for the treatment of weight loss in HIV-infected individuals: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435912/2/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome:_Cochrane_systematic_review
Anabolic Steroids for the Treatment of Weight Loss in HIV-infected Individuals: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435912/2/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anabolic steroids for the treatment of weight loss in HIV-infected individuals: Cochrane systematic review
ID - 435912
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435912/2/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -